Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial.

Hoover DA, Capaldi DP, Sheikh K, Palma DA, Rodrigues GB, Dar AR, Yu E, Dingle B, Landis M, Kocha W, Sanatani M, Vincent M, Younus J, Kuruvilla S, Gaede S, Parraga G, Yaremko BP.

BMC Cancer. 2014 Dec 11;14:934. doi: 10.1186/1471-2407-14-934.

PMID:
25496482
[PubMed - in process]
Free Article
2.

Tolerability of the combination of ginger (Zingiber officinalis), gentian (Gentiana lutea) and turmeric (Curcuma longa) in patients with cancer-associated anorexia.

Sanatani M, Younus J, Stitt L, Malik N.

J Complement Integr Med. 2014 Oct 17. pii: /j/jcim.ahead-of-print/jcim-2013-0064/jcim-2013-0064.xml. doi: 10.1515/jcim-2013-0064. [Epub ahead of print]

PMID:
25324460
[PubMed - as supplied by publisher]
3.

Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care system.

Ellis PM, Verma S, Sehdev S, Younus J, Leighl NB.

J Thorac Oncol. 2013 Sep;8(9):1136-41. doi: 10.1097/JTO.0b013e31829f6a43.

PMID:
23887170
[PubMed - indexed for MEDLINE]
4.

Prognostic factors for male breast cancer: similarity to female counterparts.

Yu E, Stitt L, Vujovic O, Joseph K, Assouline A, Au J, Younus J, Perera F, Tai P.

Anticancer Res. 2013 May;33(5):2227-31.

PMID:
23645780
[PubMed - indexed for MEDLINE]
5.

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy.

Teft WA, Gong IY, Dingle B, Potvin K, Younus J, Vandenberg TA, Brackstone M, Perera FE, Choi YH, Zou G, Legan RM, Tirona RG, Kim RB.

Breast Cancer Res Treat. 2013 May;139(1):95-105. doi: 10.1007/s10549-013-2511-4. Epub 2013 Apr 12. Erratum in: Breast Cancer Res Treat. 2013 Nov;142(1):225.

PMID:
23580071
[PubMed - indexed for MEDLINE]
6.

Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis.

Younus J, Vandenberg T, Jawaid M, Jawaid MA.

Curr Oncol. 2012 Dec;19(6):332-4. doi: 10.3747/co.19.1174. No abstract available.

PMID:
23300360
[PubMed]
Free PMC Article
7.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators.

Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22.

PMID:
23177515
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The impact of post-mastectomy radiation therapy on male breast cancer patients--a case series.

Yu E, Suzuki H, Younus J, Elfiki T, Stitt L, Yau G, Vujovic O, Perera F, Lock M, Tai P.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):696-700. doi: 10.1016/j.ijrobp.2011.01.010. Epub 2011 Mar 11.

PMID:
21398053
[PubMed - indexed for MEDLINE]
9.

Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy.

Lock M, Sinclair K, Welch S, Younus J, Salim M.

Oncol Lett. 2011 Jan;2(1):85-90. Epub 2010 Oct 5.

PMID:
22870134
[PubMed]
Free PMC Article
10.

What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?

Yu E, Tai P, Malthaner R, Stitt L, Rodrigues G, Dar R, Yaremko B, Younus J, Sanatani M, Vincent M, Dingle B, Fortin D, Inculet R.

Curr Oncol. 2010 Nov;17(6):46-51.

PMID:
21151409
[PubMed]
Free PMC Article
11.

Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.

Younus J, Verma S, Franek J, Coakley N, Sacroma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.

Curr Oncol. 2010 Aug;17(4):4-10.

PMID:
20697509
[PubMed]
Free PMC Article
12.

Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.

Waters E, Dingle B, Rodrigues G, Vincent M, Ash R, Dar R, Inculet R, Kocha W, Malthaner R, Sanatani M, Stitt L, Yaremko B, Younus J, Yu E.

Clin Lung Cancer. 2010 Jul 1;11(4):243-50. doi: 10.3816/CLC.2010.n.031.

PMID:
20630826
[PubMed - indexed for MEDLINE]
14.

Management of aromatase inhibitor-induced arthralgia.

Younus J, Kligman L.

Curr Oncol. 2010 Feb;17(1):87-90.

PMID:
20179809
[PubMed]
Free PMC Article
15.

Management of hot flashes in women with breast cancer.

Kligman L, Younus J.

Curr Oncol. 2010 Feb;17(1):81-6.

PMID:
20179808
[PubMed]
Free PMC Article
16.
17.

Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience.

Yu E, Tai P, Younus J, Malthaner R, Truong P, Stitt L, Rodrigues G, Ash R, Dar R, Yaremko B, Tomiak A, Dingle B, Sanatani M, Vincent M, Kocha W, Fortin D, Inculet R.

Curr Oncol. 2009 Aug;16(4):48-54.

PMID:
19672424
[PubMed]
Free PMC Article
18.

An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

Verma S, Sehdev S, Joy A, Madarnas Y, Younus J, Roy JA.

Curr Oncol. 2009 Jul;16 Suppl 2:S1-13.

PMID:
19672416
[PubMed]
Free PMC Article
19.

Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer.

Louie AV, Rodrigues G, Yaremko B, Yu E, Dar AR, Dingle B, Vincent M, Sanatani M, Younus J, Malthaner R, Inculet R.

Clin Lung Cancer. 2009 May;10(3):174-9. doi: 10.3816/CLC.2009.n.024.

PMID:
19443337
[PubMed - indexed for MEDLINE]
20.

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.

Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

Curr Oncol. 2008 Apr;15(2):80-4.

PMID:
18454188
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk